Multiple Sclerosis Global Support Network News

"Your trusted source for the latest in MS news and information."

  • MS Info Hub
  • MS News

ECTRIMS 2017: MS World Reports – Dr. Daniel Kantor speaks about...

Dr. Daniel Kantor speaks with Dr. Stacey Cofield, Associate Professor of Biostatistics at University of Alabama about a study conducted on Smoking and Multiple...

ECTRIMS 2017: MS Places Heavy Burdens on Women, Study in 8...

Multiple sclerosis (MS) can have severe implications on the lives of European women with the disease, finds a new report, affecting their education, their...

ECTRIMS 2017: Advances in Progressive and Pediatric MS Top ECTRIMS Highlights,...

A giant leap in research and interest in progressive multiple sclerosis — from a few people pushing for such work to 2,000 listening to...

ECTRIMS 2017: MS World Reports – Dr. Daniel Kantor speaks about...

Dr. Daniel Kantor speaks about the International Progressive MS Alliance and what's new in terms of research. The Multiple Sclerosis Global Support Network (MSGSN) is...

ECTRIMS 2017: Ruth Ann Marrie, MD, PhD: Collaborative Care and Comorbid...

Ruth Ann Marrie, MD,PhD, FRCP, associate professor of medicine and health sciences at the University of Manitoba: Well, I’m lucky enough to work in a...

ECTRIMS 2017: Mark Freedman discusses recent developments and unmet needs in...

Mark Freedman discusses recent developments and unmet needs in MS. Mark Freedman has received honoraria or consultation fees from Bayer Healthcare, Biogen-Idec, Chugai, EMD Canada,...

ECTRIMS 2017: Nicolas Dubuisson – The development of a smartphone application...

Nicolas Dubuisson talks to us about the topic of his presentation, the development of a smartphone application that enables visual function in MS to...

ECTRIMS 2017: Two Phase 3 Trials Show Ozanimod Effective in Relapsing...

PARIS — Full findings from the phase 3 SUNBEAM and RADIANCE trials expand on previously released topline results showing that the investigational oral agent ozanimod (RPC1063,...

ECTRIMS 2017: Robert Zivadinov, MD: The Clinical Takeaways of the TOPIC...

Robert Zivadinov, MD, professor of neurology at the University of Buffalo: If you asked me, “Can community neurologists assess the cortical atrophy in the way...

ECTRIMS 2017: Ocrevus Trial Data May Lead to Key Biomarkers of...

Potential new ways of capturing disease progression in multiple sclerosis (MS) patients — including those with chronic as opposed to active inflammation — are...